Abstract: Effective management of postoperative pain is essential to ensure patient welfare, reduce morbidity and optimize recovery. Opioids are effective in managing moderate to severe pain in horses but concerns over their adverse effects on gastrointestinal (GI) motility and associated increased colic risk limit their widespread use. Studies investigating the impact of systemic opioids on both GI motility and colic incidence in horses have yielded inconclusive outcomes. Therefore, this retrospective study aims to assess the influence of systemic administration of butorphanol, morphine, and methadone on post-anaesthetic colic (PAC) incidence. Horses undergoing general anaesthesia for non-gastrointestinal procedures that were hospitalized for at least 72 h post-anaesthesia were included in this study. Anaesthetised horses were stratified by procedure type into horses undergoing diagnostic imaging without surgical intervention, emergency or elective surgery. In addition, patients were grouped by opioid treatment regime into horses receiving no opioids, intraanaesthetic, short- (<24 h) or long-term (>24 h) postoperative opioids. Administered opioids encompassed butorphanol, morphine and methadone. The number of horses showing signs of colic in the 72 h after anaesthesia was assessed for each group. A total of 782 horses were included, comprising 659 undergoing surgical procedures and 123 undergoing diagnostic imaging. The overall PAC incidence was 15.1%. Notably, horses undergoing diagnostic imaging without surgery had a significantly lower PAC rate of 6.5% compared to those undergoing surgery (16.7%, = 0.0146). Emergency surgeries had a significantly lower PAC rate of 5.8% compared to elective procedures (18%, = 0.0113). Of the 782 horses, 740 received intraoperative opioids and 204 postoperative opioids, 102 of which long-term (≥24 h). Neither intraoperative ( = 0.4243) nor short-term postoperative opioids ( = 0.5744) increased PAC rates. Notably, only the long-term (≥24 h) administration of morphine significantly increased PAC incidence to 34% ( = 0.0038). In contrast, long-term butorphanol (5.3% PAC, = 0.8482) and methadone (18.4% PAC, = 0.6161) did not affect PAC rates. In summary, extended morphine administration was the only opioid treatment associated with a significantly increased risk of PAC.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
This research looks into the effect of pain relief drugs butorphanol, morphine, and methadone on the occurrence of colic after anesthesia among horses. The findings indicate that only long-term use of morphine was observed to significantly increase the incidence of post-anaesthetic colic.
Study Design and Sample
This was a retrospective study involving 782 horses. The subjects were made up of those that underwent general anaesthesia for non-gastrointestinal procedures and stayed in hospital for at least 72 hours after anaesthesia.
The group was further divided based on the type of procedure into horses undergoing diagnostic imaging without surgical intervention, and those undergoing either emergency or elective surgery.
Another classification was based on the opioid treatment regime. These included horses not receiving any opioids, and those receiving intraanaesthetic, short-term (less than 24 hours), or long-term (more than 24 hours) postoperative opioids.
Main Findings
The overall incidence of post-anaesthetic colic (PAC) was 15.1%. A significant finding was that horses undergoing diagnostic imaging without surgery registered a significantly lower PAC rate of 6.5% compared to those undergoing surgery (16.7%).
Emergency surgeries also recorded a significantly lower PAC rate of 5.8% compared to elective procedures (18%).
Of the 782 horses, 740 received intraoperative opioids and 204 postoperative opioids, with 102 of these receiving long-term (more than 24 hours) treatment.
However, neither intraoperative nor short-term postoperative opioids were seen to increase PAC rates.
Notably, only long-term administration of morphine significantly increased the PAC incidence to 34%. In contrast, long-term butorphanol and methadone did not affect PAC rates.
Conclusions
The study concluded that extended morphine administration was the only opioid treatment associated with a significantly increased risk of post-anaesthetic colic in horses.
This is an important consideration for veterinarians when choosing pain management strategies for horses, taking into account the potential higher risk of colic from long-term morphine use.
Cite This Article
APA
Haralambus R, Juri M, Mokry A, Jenner F.
(2024).
The impact of opioid administration on the incidence of postanaesthetic colic in horses.
Front Pain Res (Lausanne), 5, 1347548.
https://doi.org/10.3389/fpain.2024.1347548
Equine Surgery Unit, University Equine Hospital, Department of Companion Animals and Horses, University of Veterinary Medicine Vienna, Vienna, Austria.
Juri, Michaela
Equine Surgery Unit, University Equine Hospital, Department of Companion Animals and Horses, University of Veterinary Medicine Vienna, Vienna, Austria.
Mokry, Anna
Equine Surgery Unit, University Equine Hospital, Department of Companion Animals and Horses, University of Veterinary Medicine Vienna, Vienna, Austria.
Jenner, Florien
Equine Surgery Unit, University Equine Hospital, Department of Companion Animals and Horses, University of Veterinary Medicine Vienna, Vienna, Austria.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Corsetti M, Pannemans J, Whorwell P. Targeting mu opioid receptors to modulate gastrointestinal function: what have we learnt so far from the studies in functional bowel disorders?. F1000Res (2019) 8:F1000 Faculty Rev-257.
Galligan JJ, Sternini C. Insights into the role of opioid receptors in the GI tract: experimental evidence and therapeutic relevance.. Handb Exp Pharmacol (2017) 239:363–78.
Mosiska P, Zieliska M, Fichna J. Expression and physiology of opioid receptors in the gastrointestinal tract.. Curr Opin Endocrinol Diabetes Obes (2016) 23:3–10.
Sobczak M, Sałaga M, Storr MA, Fichna J. Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives.. J Gastroenterol (2014) 49:24–45.
Yuan C-S. Clinical status of methylnaltrexone, a new agent to prevent and manage opioid-induced side effects.. J Support Oncol (2004) 2:111–7; discussion 119–22.
Mercadante S, Casuccio A, Fulfaro F, Groff L, Boffi R, Villari P. Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study.. J Clin Oncol (2001) 19:2898–904.
Jago RC, Corletto F, Wright IM. Peri-anaesthetic complications in an equine referral hospital: risk factors for post anaesthetic colic.. Equine Vet J (2015) 47:635–40.
Mancini IL, Hanson J, Neumann CM, Bruera ED. Opioid type and other clinical predictors of laxative dose in advanced cancer patients: a retrospective study.. J Palliat Med (2000) 3:49–56.
Commiskey S, Fan L-W, Ho IK, Rockhold RW. Butorphanol: effects of a prototypical agonist-antagonist analgesic on κ-opioid receptors.. J Pharmacol Sci (2005) 98:109–16.
Imam MZ, Kuo A, Ghassabian S, Smith MT. Progress in understanding mechanisms of opioid-induced gastrointestinal adverse effects and respiratory depression.. Neuropharmacology (2018) 131:238–55.
Wolff RF, Aune D, Truyers C, Hernandez AV, Misso K, Riemsma R. Systematic review of efficacy and safety of buprenorphine versus fentanyl or morphine in patients with chronic moderate to severe pain.. Curr Méd Res Opin (2012) 28:833–45.
Kuo A, Wyse BD, Meutermans W, Smith MT. In vivo profiling of seven common opioids for antinociception, constipation and respiratory depression: no two opioids have the same profile.. Br J Pharmacol (2013) 172:532–48.
Mori T, Shibasaki Y, Matsumoto K, Shibasaki M, Hasegawa M, Wang E. Mechanisms that underlie μ-opioid receptor agonist–induced constipation: differential involvement of μ-opioid receptor sites and responsible regions.. J Pharmacol Exp Ther (2013) 347:91–9.
Matsumoto K, Umemoto H, Mori T, Akatsu R, Saito S, Tashima K. Differences in the morphine-induced inhibition of small and large intestinal transit: involvement of central and peripheral μ-opioid receptors in mice.. Eur J Pharmacol (2016) 771:220–8.
Camilleri M, Lembo A, Katzka DA. Opioids in gastroenterology: treating adverse effects and creating therapeutic benefits.. Clin Gastroenterol Hepatol (2017) 15:1338–49.
Lay J, Carbone SE, DiCello JJ, Bunnett NW, Canals M, Poole DP. Distribution and trafficking of the μ-opioid receptor in enteric neurons of the Guinea pig.. Am J Physiol-Gastrointest Liver Physiol (2016) 311:G252–66.
Schepper HUD, Cremonini F, Park M-I, Camilleri M. Opioids and the gut: pharmacology and current clinical experience.. Neurogastroenterol Motil (2004) 16:383–94.
Shook JE, Pelton JT, Lemcke PK, Porreca F, Hruby VJ, Burks TF. Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptor-related functions.. J Pharmacol Exp Ther (1987) 242:1–7.
Holzer P. Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans.. Neurosci Lett (2004) 361:192–5.
Daeninck PJ, Bruera E. Reduction in constipation and laxative requirements following opioid rotation to methadone.. J Pain Symptom Manag (1999) 18:303–9.
Leppert W. The impact of opioid analgesics on the gastrointestinal tract function and the current management possibilities.. Contemp Oncol (2012) 16:125–31.
Gershon MD. Review article: serotonin receptors and transporters—roles in normal and abnormal gastrointestinal motility.. Aliment Pharmacol Ther (2004) 20:3–14.
Kuo CP, Jao SW, Chen KM, Wong CS, Yeh CC, Sheen MJ. Comparison of the effects of thoracic epidural analgesia and i.v. Infusion with lidocaine on cytokine response, postoperative pain and bowel function in patients undergoing colonic surgery.. Br J Anaesth (2006) 97:640–6.